August 16th, 2018
SPR Therapeutics, a Cleveland, Ohio firm, landed clearance from the FDA for its SPRINT endura and extensa peripheral percutaneous electric nerve stimulators (PENS). The endura is a single lead system, while the extensa is dual lead.
The two devices represent the only FDA cleared dual-lead capable percutaneous electrical...